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Abstract: The interest in measuring physiological parameters (especially arterial blood 
gases) has grown progressively in parallel to the development of new technologies. 
Physiological parameters were first measured invasively and at discrete time points; 
however, it was clearly desirable to measure them continuously and non-invasively. The 
development of intensive care units promoted the use of ventilators via oral intubation 
ventilators via oral intubation and mechanical respiratory variables were progressively 
studied. Later, the knowledge gained in the hospital was applied to out-of-hospital 
management. In the present paper we review the invasive and non-invasive techniques for 
monitoring respiratory variables. 
Keywords: physiological parameters; transcutaneous arterial oxygen saturation; 
transcutaneous partial pressure of carbon dioxide; capnometry; mechanical respiratory 
parameters; mechanical ventilation; home care; telemonitoring 
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Abbreviations 
PaO2  arterial oxygen partial pressure 
PaCO2 arterial anhydride carbonic acid pressure 
ABG  arterial blood gas  
SpO2  transcutaneous arterial oxygen saturation 
SaO2  arterial oxygen saturation obtained from arterial blood gas analysis 
TcCO2 transcutaneous partial pressure of carbon dioxide 
FEV1  forced spirometric value in the first second 
FVC forced  vital  capacity 
PFTs pulmonary  function  testings 
V    flow over time 
V volume 
Prs pressure  applied  to  the respiratory system  
Pmus  pressure developed by the respiratory muscles  
Pao  pressure at the airway opening  
Pres  frictional forces generated with gas flow  
Rrs  resistance of the respiratory system  
Pel  elastic forces  
Crs  respiratory system compliance  
PEEP  positive end-expiratory pressure  
PEEPi. Intrinsic PEEP 
Pmax  highest peak at end-inspiration  
Pst, rs  static pressure of the respiratory system  
Palv alveolar  pressure   
NIV non-invasive  ventilation  
ALI/ARDS acute  lung  injury/adult  respiratory distress syndrome 
1. Introduction 
In the 1950s, reports of blindness caused by oxygen therapy administered to premature babies drew 
attention to the need to develop non-invasive techniques for measuring PaO2. Later, clinicians became 
interested in measuring PaCO2 as well. An important milestone was the introduction of pulse oximetry 
in 1985, which provided effective non-invasive assessment of oxygenation during sleep and exercise. 
Pulse oximetry cannot, however, provide information on PaCO2, so it cannot provide information 
about the patient’s ventilation. Therefore, the development of techniques for non-invasive monitoring 
of PaCO2 became a priority.  
Interest in measuring physiological parameters grew progressively in parallel with the development 
of new technologies and intensive care units (ICU). Physiological parameters were first measured 
invasively and at discrete time points; however, it was clearly desirable to measure these parameters 
continuously and non-invasively. The development of ICUs promoted the use of ventilators via oral 
intubation, and mechanical respiratory variables were progressively studied. Later, the knowledge 
gained in the hospital was applied to out-of-hospital management, and devices were developed Sensors 2010, 10                                       
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designed to provide ambulatory care for chronic diseases [1-3], further increasing the interest in   
non-invasive monitoring methods. In the last two decades, telemedicine has developed in parallel with 
new technology (sensors and devices) [4,5]. Telemonitoring is emerging as a highly promising way of 
managing the large numbers of patients with chronic illness [6,7]. The most sophisticated telemedicine 
systems offer real-time visualization of patients at home and of their physiological data [8,9]. 
2. Non-Invasive Measurement of Blood Gases 
In the pulmonary field, arterial blood gases and airflow are the target parameters to be measured. 
Techniques for assessing arterial blood gases were first developed for measuring oxygenation [10,11] 
and then for measuring PaCO2 as well [12,13]. However, interest in non-invasive measurement of both 
PaCO2 and PaO2 gradually faded in view of the technical and practical problems associated with the 
measuring devices used (Table 1) [11]. 
Table 1. Drawbacks of traditional devices for transcutaneous measurement of carbon dioxide. 
 
 
 
2.1. Arterial Oxygen Measurement 
The physiological basis of blood gas pressure determination through the arterialization of capillary 
blood derives from experiments conducted by Baumberger and Goodfriend more than 50 years ago [14]. 
These authors demonstrated that if the surface of human skin is heated to the maximum supportable 
temperature (approximately 45 °C), the pressure of oxygen in the skin increases to approach that of the 
pressure in arterial blood. Twenty years later, Huch et al. showed that PaO2 in premature and newborn 
babies could be measured with an electrode heated to 43 °C to 44 °C [15]. Interest was initially 
focused on determining PaO2 transcutaneously, as this was the only non-invasive alternative to 
invasive arterial gasometry. However, the development of pulse oximetry largely supplanted the 
traditional transcutaneous determination. Moreover, recent studies have shown that transcutaneous 
measurement systematically underestimates arterial PaO2 [16]. Despite the controversy surrounding 
the accuracy of transcutaneous oxygen measurement, in certain countries such as Germany, 
Switzerland and Austria transcutaneous oximetry based on the arterialization of capillary blood is 
widely used in neonatal ICUs [17].  
Although the gold standard continues to be invasive blood gas monitoring through arterial puncture, 
pulse oximetry has proven effective for non-invasive assessment of oxygenation during sleep [10] as 
well as during exercise [11], and has become widely used since its introduction in 1985. Several 
factors, including race, smoking, and jaundice may influence pulse oximeter readings [11]. Recently, 
during the validation of a new pulse oximeter [12], we observed that oxygen saturation readings 
became reliable only two minutes after placing the device, although in clinical practice readings are 
Burns resulting from the high temperature of the electrodes 
Skin abrasion resulting from excessive friction of the electrodes 
Unreliable readings in patients with acidosis 
Long times for calibration and stabilization 
Need to change application site of the electrodes every 2-4 hours Sensors 2010, 10                                       
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often recorded almost immediately. Pulse oximetry cannot, however, measure PaCO2, so it cannot 
inform us about the patient’s ventilation. 
2.2. Arterial CO2 Measurement 
Whereas non-invasive arterial oxygen saturation monitoring using pulse oximetry has proven 
reliable, non-invasive monitoring of PaCO2 remains controversial. Two techniques are of special 
interest in the non-invasive estimation of PaCO2: capnography (based on capnometry) and 
transcutaneous CO2 measurement.  
2.2.1. Capnometry-Capnography 
Capnography has long been the standard of care for the non-invasive estimation of PaCO2 in many 
health disciplines, including anesthesiology, and pulmonary, critical care, and emergency medicine. 
Capnometry refers to the continuous measurement of CO2 in exhaled air, which is often accomplished 
by infrared spectrometric analysis during the respiratory cycle. All capnographs provide a single value 
for CO2, usually from end-respiration to end-respiration, designated end-tidal CO2 (EtCO2). When 
capnometric values are displayed as breath-to-breath CO2 elimination curves, the technique is referred 
to as capnography.  
Two main types of capnographs are commonly available. The first, mainstream capnometry, uses a 
sensor placed directly in the airway through which the patient exhales – in most cases, the orotracheal 
tube. The signal generated is analyzed in the sensor itself and then electronically transmitted to the 
device, which shows the readings on a screen. The second type, sidestream capnometry, continually 
aspirates samples of expired air to be processed in the device [13]. Although no significant differences 
between measurements from the two types have been found, mainstream capnometry is more common 
in critical patients because its response is quicker and it has none of the complications derived from the 
aspiration of air (mainly due to obstruction of the device).  
2.2.1.1. Physiological Basis for Capnography Interpretation. 
Despite the relatively simple technology behind capnography and the ease with which capnographic 
measurements are obtained, the interpretation of the results requires a profound knowledge of the 
physiological bases of CO2 production, transport, and elimination.  
CO2 production. CO2 is the end product of aerobic metabolism in tissues. In normal conditions, the 
ratio of CO2 production to oxygen consumption (the respiratory coefficient) is 0.8. However, tissue 
CO2 production increases in certain situations (fever, intense physical exercise, convulsions, or 
hyperthyroidism, among others) and decreases in others (sedation, hypothermia, and hypothyroidism).  
Transport. CO2 is transported in three fundamental ways: directly dissolved in blood (making up 10% 
of venous blood), as a bicarbonate anion (75%–80%), and as carbamino compounds (10%). 
Fluctuations in cardiac output will thus influence CO2 transport until it is eliminated through 
ventilation. Thus, CO2 accumulates in the venous compartment when cardiac output is low and CO2 
accumulation is greatest during circulatory arrest.  
Elimination: CO2 is eliminated through the lungs by alveolar ventilation. Therefore, appropriate 
CO2 elimination requires the integrity of the components involved in ventilation and perfusion. The Sensors 2010, 10                                       
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components involved in ventilation can be divided into the portion of the airway that intervenes in gas 
exchange (alveolar) and the portion of the airway that does not intervene in gas exchange (dead space). 
The dead space comprises the conducting airways of the respiratory tract (anatomic dead space) and 
areas that are ventilated but that do not participate in perfusion (physiological dead space).  
Thus, the value of EtCO2 depends on extrapulmonary factors (endogenous tissue production and 
transport of CO2 to the lungs) as well as pulmonary factors (CO2 clearing by alveolar ventilation). In 
baseline conditions (cardiac output within the normal ranges, absence of situations causing 
hyperproduction or underproduction of cellular CO2), the gradient between PaCO2 and EtCO2 – P(a-
et)CO2, see below–ranges between 1 to 3 mmHg.  Changes in the P(a-et)CO2 gradient have been 
studied in several clinical and experimental situations. In an animal model of hemorrhagic shock [18], 
progressive exsanguination decreased cardiac output and the diminished capacity of transport of CO2 
to the lungs was reflected in lower than expected EtCO2 values. The P(a-et)CO2 gradient peaked in 
advanced phases of exsanguination (up to 10 mmHg).  
 
2.2.1.2. The capnogram: the Graphical Representation of Capnometry, the Normal Capnogram 
 
Capnograms can show ventilation in one of two ways: graphs resulting from plotting CO2/time and 
those resulting from plotting CO2/volume. The usual representation is CO2/time, with PaCO2 on the  
X-axis and time on the Y-axis. Phases of the capnogram: the shape of the capnogram usually has three 
(optionally four) phases and two angles (Figure 1).  
Figure 1. Phases and angles of a capnogram. 
 
 
Phase I represents the clearing of the dead space at the beginning of an expiration; in normal 
conditions, the dead space is void of CO2. In phase II, the value of CO2 increases abruptly, reflecting 
the transition from clearing the large caliber airways to clearing the first alveolar units. Phase III, the 
alveolar plateau, which lasts throughout most of the expiration, reflects the CO2 content of millions of 
alveolar units each with different CO2 concentrations. Thus, both phase III and the value of CO2 at the 
end of phase IIl (EtCO2) are products of the CO2 mixture contained in these millions of alveolar units. Sensors 2010, 10                                       
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Occasionally, a fourth phase (phase IV) in which an abrupt increase in CO2 is seen at the end of phase 
III is encountered in patients with conditions like pregnancy or significant obesity [19].  
Angles in the capnogram. In normal conditions, the angle formed between phases II and III (alpha) 
is approximately 110°. This angle can increase in certain situations; for example, the slope of phase III 
of the capnogram typically increases in patients with altered ventilation-perfusion (increased phase III 
slope basically indicates a lack of homogeneity). The second angle in the capnogram (beta) occurs 
between phase III and the start of the inspiration (CO2 = 0). In normal conditions, the beta angle is 
about 90 to 110 degrees; however, it can increase in situations where CO2 is reinhaled (for example, 
when non-invasive ventilation is supplied through a single tube without an expiratory valve). In 
addition to being able to recognize the normal shape of the capnogram, physicians need to be familiar 
with the most common abnormal shapes that can occur. Table 2 summarizes the most common 
capnographic abnormalities and the situations in which they usually arise.  
Table 2. Abnormalities in the capnogram. 
  Abnormality Setting   
Inspiratory phase (0)  CO2 > 0%  Rebreathing 
Phase I  Increased length of phase I  Increased dead space 
Excessive PEEP  
Phase II  Decreased phase II slope  Decreased perfusion (PTE, excessive 
PEEP, low cardiac output) 
Phase III  Increased phase III slope  Inhomogeneous V/Q:  
- Airway obstruction  
- Suboptimal PEEP  
α angle  Increased angle  The same situations that increase the 
slope of phase III 
β angle  Increased  angle  Reinhalation of alveolar gas: 
malfunctioning expiratory valve 
2.2.1.3. Volumetric Capnography. The Importance of the P(a-et)CO2 Gradient 
An alternative way of graphically representing capnometric information is by plotting expiratory 
CO2 on the X-axis and volume on the Y-axis. These capnograms are obtained by incorporating a 
pneumotachograph to the capnograph in order to provide continuous measures of CO2 elimination as a 
function of the volume of gas expired. The combination of airflow and capnography monitoring allows 
calculation of breath by breath CO2 production and pulmonary dead space. Therefore, the use of 
volumetric capnography is clinically more useful than time-based capnography. As shown in Figure 2, 
there is a procedure for measuring physiological dead space based on the geometric method of 
equivalent areas (p = q), obtained by crossing the back extrapolation of phase III of the expired CO2 
concentration over time with a vertical line traced so as to make the p and q areas equal. Airway dead 
space is then measured from the beginning of expiration to the point where the vertical line crosses the 
volume axis.  
Estimating the dead space is important for determining ventilator settings in patients with ARDS. 
Positive end-expiratory pressure (PEEP) is used to increase lung volume and to improve oxygenation 
in these patients. However, this technique may be helpful or harmful. On the one hand, PEEP recruits Sensors 2010, 10                                       
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collapsed lung units and improves oxygenation, thus reducing the alveolar dead space since alveolar 
recruitment is associated with decreased P(a-et)CO2; on the other, PEEP-induced overdistension may 
increase dead space and widen this difference. Thus, the P(a-et)CO2 gradient reflects the physiological 
dead space. In ideal ventilation-perfusion conditions, the value of EtCO2 is situated between 1 and 3 
mmHg lower than the PaCO2 measured in arterial blood; this difference is known as the P(a-et)CO2 
gradient. However, in some situations this gradient can suffer considerable variations, and it is crucial 
to take these situations into account when monitoring critical patients by capnography. Table 2 shows 
the main causes of increases in the P(a-et)CO2 gradient (PaCO2 more than 3 mmHg higher than 
EtCO2) and of decreases in the gradient (PaCO2 less than 1 mmHg higher than EtCO2; the gradient can 
even be negative (EtCO2 > PaCO2)).  
Figure 2. The measurement of exhaled and arterial CO2 makes it possible to represent the 
dead space. 
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Generally speaking, the P(a-et)CO2 gradient increases in conditions that increase dead space; in 
other words, P(a-et)CO2 is proportional to the dead space/tidal volume coefficient (VD/VT). Thus, 
diseases like chronic obstructive pulmonary disease or even conditions characterized by low cardiac 
output [20] cause an increase in ventilation respect to perfusion and an increased P(a-et)CO2. On the 
other hand, negative gradients can occur in situations involving hyperproduction of CO2 (fever, sepsis, 
hyperthyroidism, exercise) and even in expiration maneuvers prolonged beyond the tidal volume, 
especially in spontaneously ventilated patients (see below). Both possibilities must be kept in mind, 
both at the start of monitoring and when interpreting changes in either direction. For example, a drop 
in EtCO2 in a patient without significant changes in ventilation can indicate low cardiac output, 
whether due to hypovolemia or to heart failure from other causes. On the other hand, in a patient with 
fever and a gradient of 3 mmHg, EtCO2 may increase to values greater than PaCO2, resulting in a 
negative gradient. Likewise, it is important to bear in mind that EtCO2 reflects the “peak” 
concentration of CO2 in a few particular alveolar units, mainly with a low V/Q ratio (but greater than 
0, given that they are reflected in the capnogram), whereas PaCO2 is the mean product of millions of 
alveolar units with different V/Q ratios. Thus, the P(a-et)CO2 gradient is essentially an indicator of Sensors 2010, 10                                       
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alterations in ventilation/perfusion with mainly cardiopulmonary causes and is directly proportional to 
the degree of physiological dead space.  
In spontaneously breathing patients, several attempts have been made to study the correlation 
between PaCO2 and EtCO2 in different clinical settings such as pulmonary embolism [21] and in 
patients with a variety of pulmonary diseases in an emergency department [22]. Moreover, in 
spontaneously breathing patients, the breathing pattern and especially the depth of the expiratory 
maneuvers have also been found to influence the P(a-et)CO2 gradient [23].  
There may be alveolar units with a prolonged time constant due to bronchial narrowing which do 
not empty during tidal breathing. The CO2 of these alveolar units tends to equilibrate with mixed 
venous P CO2 values. In a longer expiratory maneuver, the greater expiratory time may allow lung 
units with low ventilation-perfusion ratio (V/Q) to empty and to be represented in a capnogram. This 
phenomenon has also been described by other authors [13-30].  
2.2.2. Transcutaneous CO2 Measurement. 
The basis for the transcutaneous measurement of PaCO2 was first described by Severinghaus et al. 
in the 1960s. These authors demonstrated that there is a linear relationship between cutaneous and true 
PaCO2 in the range of 20 to 75 mmHg. At the turn of the new century, Rohling and Biro [24] and 
Tschupp and Fanconi [25] published the first articles on monitors that incorporated the elements of an 
optical pulse oximetry sensor with a Severinghaus-type PaCO2 sensor [26]. Today, the transcutaneous 
non-invasive estimation of arterial PaCO2 is commonly accepted and widely used.  
The main technical problems in the systematic use of transcutaneous PaCO2 are due to the 
electrochemical nature of the commercially available sensors. Briefly, there are two main problems: 
the learning process (the proper placement of the sensor and the management of the device require a 
minimal degree of expertise) and the consumption of materials such as membranes or gas for 
calibration. These sensors need systematic calibration before each measurement and the membrane of 
the electrochemical sensor needs to be changed after a period of time that varies between the different 
devices; while some companies indicate that membranes should be changed before each measurement, 
others recommend that they should be changed every two weeks).  
Measurements of transcutaneous CO2 can be used in two ways, each of which has some particular 
features of its own:  
a) As a non-invasive substitute for arterial blood gases for discrete measurements in the pulmonary 
function laboratory or in emergency departments. In this setting, a key point that remains to be 
established is the point in time when the monitor offers the most reliable measurement, which can be 
influenced by the “overshoot phenomenon”: two opposing phenomena may interfere with TcCO2 
readings during the first few minutes of monitoring. First, the arterialization of capillary blood due to 
vasodilation takes several minutes. Second, applying heat increases the metabolism of the cells in the 
surface of the skin, raising CO2 release from these cells and causing a transitory overestimation of true 
PaCO2 ( Figure 3). Overshoot usually precedes the complete vasodilation of subdermal tissue [27].  Sensors 2010, 10                                       
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Figure 3. Graphic representation of the overshoot phenomenon. 
0
50
02 0
No overshoot
Mild
Moderate
Severe
Overall
Time (min)
P
a
C
O
2
m
m
H
g
 
 
Overshoot seems to vary among individuals and therefore cannot be predicted before monitoring. 
Early high TcCO2 readings may warn the clinician of its presence, although their interpretation 
depends on the patient’s baseline PaCO2 [28].  
b) As a monitoring tool that provides continuous estimates of arterial PaCO2. In this setting, two 
main drawbacks should be mentioned: 
The delay in detecting acute events, which is estimated at about 2 min. This means that short events, 
like sleep apneas, often go undetected by the device.  
Shifts during prolonged periods of monitoring. In some devices, the magnitude of the shift may 
reach values as high as 1.3 mmHg/hour of monitoring. Some commercial devices systematically 
correct the shift, but it is important that staff that manage the device are aware of it.  
Despite these limitations, transcutaneous CO2 monitoring may be a useful adjunct in various clinical 
scenarios and should help improve control and therapy in many patients in the coming years [29]. 
Optical sensors may overcome some of the drawbacks associated with the current electrochemical 
sensors; they determine CO2 by measuring its optical absorption in the evanescent wave of a 
waveguide integrated in their surface. In a preliminary study [30], the accuracy of optical sensors was 
similar to that of commercially available electrochemical sensors. Optical sensors have the following 
advantages over electrochemical sensors: they do not require systematic calibration and membrane 
replacement; there is no shift, and their response is faster. Therefore, it is likely that optical sensors 
will supplant electrochemical sensors in transcutaneous monitoring of arterial blood gases.   
2.3. Combined Estimation of PaO2 and Arterial CO2. 
Certain commercially available monitors offer transcutaneous measurement of both transcutaneous 
CO2 and O2. Many of these devices also allow the physician to set the working temperature of the 
electrode applied to the skin. Thus, while transcutaneous pO2 measurement can require working Sensors 2010, 10                                       
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temperatures of 45 °C, temperatures between 41 °C and 42 °C suffice for TcCO2 measurement, 
although some authors have reported that TcCO2 measurements are more accurate at higher 
temperatures and recommend 43 °C for measuring both transcutaneous CO2 and O2. Nevertheless, as 
stated above, even at high temperatures, the correlation between transcutaneous O2 and PaO2 is suboptimal.  
In a previous study our group validated a combined ear-lobe sensor SpO2/ transcutaneous CO2 [3], 
finding a good correlation between TcCO2/PaCO2 and SpO2/SaO2. We also determined that the 
monitor needed a maximum stabilization time of 17 minutes to allow PaCO2 readings. In later work 
we established that the ideal time to obtain readings ranged from 10 to 12 minutes, due to the 
overshoot phenomenon.  
3. Physiologic Parameters Evaluated during Mechanical Ventilation. 
In mechanically ventilated patients, respiratory mechanics can be measured in dynamic (no flow 
interruption) or static (occlusion technique) conditions. Modern ventilators employed in ICUs measure 
breath-by-breath flow (V  ), volume (V), and pressure at the airway opening (Pao) and display the 
information graphically in real time as curves against time or as combined loops. Data obtained from 
curves analysis can help physicians understand the complex interactions between patients and 
ventilators. 
Assisted ventilation can be total, partial, or absent, depending on the respiratory muscles’ ability to 
generate the pressure applied to the respiratory system (Prs). The Prs of a ventilated patient is the sum 
of the pressure generated by the ventilator Pao and the pressure developed by the respiratory muscles 
(Pmus). The latter is negative, as inspiratory muscles act by producing a decrease in pressure below the 
airways, as described by the equation of motion [31-33]. 
k
C
V R V Pmus Pao s         ) ( Pr   
where V is the volume, V   the flow over time, and k is a constant representing the alveolar end-
expiratory pressure. The term V  R   corresponds to the pressure dissipated across the airway and the 
endotracheal tube to overcome the frictional forces generated with gas flow (Pres). The rate of Pres 
and V   defines the resistance of the respiratory system (Rrs). 
The term 
C
V
, on the other hand, corresponds to the pressure that must be applied to overcome 
elastic forces (Pel), which depends on both the volume insufflated in excess of resting volume (Vr) and 
on the respiratory system compliance (Crs). The constant k takes into account the application of 
positive end-expiratory pressure (PEEP) or intrinsic PEEP (PEEPi), if present. When the patient’s 
breathing activity is entirely passive, Pmus is negligible, and the driving pressure necessary to move 
air in and out of the thorax can be described by the simplified equation of motion [31-33]: 
k
C
V R V Pao s       Pr  Sensors 2010, 10                                       
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3.1. Static Mechanics 
During mechanical ventilation the rapid airway occlusion method is the most commonly used 
technique for measuring respiratory mechanics. The mean airway pressure (Paw) wave has a 
characteristic trend with the highest peak at end-inspiration (Pmax), followed by a rapid drop after the 
occlusion (P1), and a slow decline until a plateau is reached (P2). P2 is the static pressure of the 
respiratory system (Pst, rs), which, in the absence of flow, equals the alveolar pressure (Palv), 
reflecting the elastic retraction of the entire respiratory system. The pressure drop from Pmax to P1 
represents the pressure dissipated by the flow-dependent resistances. The slow decline from P1 to P2 
after the occlusion depends on the viscoelastic properties of the system and on the pendulum-like 
movement of the air. In normal subjects, the alveolar pressure is near zero at end-expiration. Limiting 
expiratory flow or an inadequate respiratory pattern (high tidal volume or high respiratory rate) causes 
PEEPi due to volume trapping. PEEPi is detectable during the post-expiratory occlusion maneuver. 
The rapid airway occlusion technique is quick and easy to perform and provides immediate clinical 
data; this is especially useful when monitoring a paralyzed patient, even with a nonconstant flow wave, 
as occurs during pressure-controlled ventilation. Plateau pressure (P2) can be measured by applying a 
pause at end-inspiration during pressure-controlled ventilation [34-37].  
3.1.1. Time-Course of Paw during Constant Flow Inflation (Volume-Controlled Ventilation) 
Observing the pressure wave in the airway as a function of time during constant-flow ventilation in 
the absence of spontaneous inspiration provides information about the elastic load (tension) to which 
the lung parenchyma is subjected. During inspiration with constant airflow, there is a linear increase in 
flow volume. Therefore, during the constant-flow inspiratory phase, changes in the concavity or 
convexity of the pressure wave are associated with unnecessary stretching/overdistension of ventilated 
alveolar regions or to recruitment and derecruitment of alveolar regions that were collapsed at the start 
of inspiration and opened during inspiration. A linear pressure wave during inspiration indicates 
constant compliance and the absence of overdistension and/or cyclic recruitment and derecruitment of 
alveolar regions [33,35,38]. The mathematical analysis of the shape of the dynamic pressure wave in 
the airway during constant-flow ventilation has led to the coining of the term “stress index”, which can 
be analyzed breath to breath. After physiological studies in animals showed that a nonlinear pressure 
wave in the airway was associated with ventilator-induced lung injury [38], studies in ALI/ARDS 
patients confirmed these preliminary experimental data. Several authors have found that a sustained 
pattern of overdistension is associated with greater pulmonary inflammation and worse 
prognosis [39,40]. Currently, no computerized system is available for continuous monitoring of the 
stress index. No automatic methods have been developed to analyze the data stored and this 
information cannot be integrated into the electronic clinical history. 
3.2. Dynamic Mechanics 
Dynamic mechanics may be derived during spontaneous breathing and in intubated patients in 
partially or totally supported ventilation [41]. In patients ventilated with partial support, the real-time 
analysis of the curves displayed can provide a great deal of useful information.  Sensors 2010, 10                                       
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Patient-ventilator synchrony is achieved using a flow- or pressure-trigger system. In pressure-
trigger mode, the ventilatory support detects the drop in airway pressure that occurs during inspiratory 
efforts that surpass a specific threshold value (usually 0.5-1 cmH2O during assisted ventilation, 
although higher threshold values of up to −20 cmH2O may be set). Inappropriate trigger sensitivity 
may lead to increased work of breathing, delaying weaning, or  patient-ventilator dyssynchrony, and 
subsequent need for sedation. On the other hand, flow triggering has the advantages of lower 
inspiratory workload and greater sensitivity, but it sometimes triggers ventilatory support when 
patients are not spontaneously breathing (autotriggering) [42,43], which may also result from factors 
such as leaks in the circuit, expiratory fluctuations caused by water in the circuit, and cardiogenic 
oscillations [44]. 
A correct understanding of flow-trigger ventilation is important when managing non-invasively 
ventilated patients. Using masks or helmets during non-invasive ventilation (NIV) causes frequent air 
leaks and patient ventilator asynchronies during the inspiratory phase. This problem can be overcome 
by setting the bias flow as a compensating system, since its capacity reaches 20 liters/min; thus, PEEP 
can be applied without causing autotriggering [37,45]. 
Ineffective inspiratory efforts are the most common manifestation of poor patient-ventilator 
interaction [45]. The contraction of the inspiratory muscles against a closed valve has a high metabolic 
cost and can lead to the expression of inflammatory mediators in the muscles of the diaphragm [46,47]. 
Detecting ineffective inspiratory efforts should be a priority during mechanical ventilation, and 
ventilator settings (mode, airflow, tidal volume, expiratory time, and PEEP) should be adjusted to 
minimize them. A significant number of ineffective efforts is associated with increased need for 
sedation, episodes of arterial desaturation, behavioral disorders (delirium, episodes of panic, etc.), 
longer mechanical ventilation, and longer ICU stays [48,49]. 
The number of inspiratory efforts that a patient makes in a specific period of time can only be 
quantified by continuous observation of the airflow and airway pressure waves on the respirator’s 
screen or with specific algorithms [50,51]. 
3.2.1. Signal Acquisition from Medical Devices 
Up to 77% of admissions to medical ICUs take place, at least in part, for the purposes of 
monitoring, although only 10% of the patients monitored will subsequently have indications for major 
interventions [52,53]. Modern ICU equipment takes advantage of a wide range of technologies to track 
physiological variables in order to detect potentially life-threatening changes. As response time is a 
key issue, most of these devices are equipped with a more or less sophisticated set of alarms that alert 
intensivists, pulmonologists, nurses, or respiratory therapists about changes that could represent a risk 
to patients [54]. 
Current monitoring systems show waves and values. Even when alarm thresholds are based on 
values, analyzing waveforms can be very useful. Specialists tend to analyze waveforms at the bedside. 
For example, in the intracranial trace, a P2 wave greater than the P1 wave can alert the specialist to a 
drop in intracranial compliance. Persistent airway flow at end-expiration is synonymous with 
autoPEEP. Extreme variability in pulse pressure suggests the need for intravenous fluid replacement, 
and so on. However, physicians require extensive training in order to carry out these analyses. It may 
be relatively simple to implement automatic processes for evaluating these phenomena once the Sensors 2010, 10                                       
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signals from the monitoring devices have been acquired by a centralized system. To achieve this, 
information must be available in a form that is independent of the manufacturer of the monitor or 
ventilator. 
The combination of elements from different monitoring devices (pressure at airway opening, 
airflow, and capnograms) could be of clinical interest. Measuring the volume of expired CO2 (rather 
than the pressure of CO2 in expired gases, which is usually available) allows the approximate state of 
the patient’s metabolism to be estimated, and some parameters calculated from volumetric 
capnography provide information about the condition of the lungs and cardiovascular function. If the 
information from the ventilator flow sensor were combined with information from the patient’s 
capnograph (nearly always available in mechanically ventilated patients), information about the 
volume of expired CO2 would be easily available without the need for additional equipment [55-57].  
Because manufacturers of monitoring systems are concerned about avoiding false negatives (a true 
event going undetected), they lower the alarm thresholds, thereby generating excessive, often useless, 
information. Kestin et al. showed that, in the operating room, where patients are normally sedated and 
relaxed, only 3% of the alarms that went off alerted to events that represented a true risk to the patient [54]. 
In the ICU, where the manipulation of patients often causes false detections, the situation is probably 
worse, leading to a high rate of false alarms and high level of noise [58,59]. 
Incorporating monitoring systems with more complex algorithms might represent a considerable 
improvement. Currently, signals are treated as if they were completely unrelated. Even when the ECG 
and respiratory plethysmographic signals are measured by the same sensors, the malfunction of one of 
the electrodes usually triggers a low level ECG alarm (“Electrode disconnected”) and a maximum 
level alarm in the plethysmograph (“Apnea”). A more comprehensive overview is necessary to 
understand the physiological and physiopathological phenomena involved. For example, the combined 
presentation of bradycardia, hypertension, and increased intracranial pressure means much more than 
the sum of each individual phenomenon. While each element might result from many causes, the level 
of uncertainty is much lower when the three alterations present together.  
The final aim of alarm programming is patient safety. In an environment in which human resources 
are scarce, simply warning of a potentially dangerous event does not guarantee that this aim will be 
fulfilled. Therefore, incorporating expert knowledge in monitoring systems could help staff to 
understand the phenomena and suggest solutions for the problems. The level of information in medical 
registers will determine the usefulness of the information that can be offered and will thus guarantee 
patient safety while solving the problem of detecting important events [60].  
4. The Future of Telemedicine 
A telecare system consists of equipment (basically sensors and monitors) that transfers data to a 
communication controller, which then forwards the data to a monitoring center where they are stored 
in a database for subsequent access by the user. Nowadays, some of these sensors are wireless [61], 
and these systems can also operate from the patient’s home to provide chronic medical care. Sensors 2010, 10                                       
 
 
4668
4.1. Telemedicine in Emergencies 
Telemedicine is normally used to compensate for the limitations of medical resources, in which a 
remotely located physician provides care for a patient either in-hospital or elsewhere. However, this is 
not the only scenario in which telemedicine can be used. In cities, patients can usually reach 
emergency services within half an hour. In rural areas, however, the distances are greater and the 
provision of medical attention may be delayed [62]. The impact of delays in attending trauma victims 
has been studied for nearly a century. An analysis of the mortality of French soldiers in World War I 
found that 10% of those resuscitated within an hour of being wounded died, compared to 75% of those 
resuscitated within 8 hours [63]. These data seem to have influenced Adams Cowley in his definition 
of the “golden hour” concept. Even though there is no hard evidence for a particular time frame [64], it 
is clear that delays in resuscitation have a significant impact on patient outcome. Rapìd attention is 
critical not just for trauma victims but for cardiovascular, neurological and respiratory emergencies, 
and also for septic diseases. 
In this latter scenario, telemedicine can help to shorten the time needed to provide the best standard 
care to the patient. In a population-based retrospective cohort study of all trauma deaths in the 
province of Ontario (Canada) between 2002 and 2003, Gomez et al. [65] found that more than half of 
the deaths occurred before patients reached the emergency department (ED): out-hospital deaths were 
twice as likely in rural locations and in areas with limited access to timely trauma center care. 
Moreover, among patients surviving long enough to reach hospital, there was a threefold increase in 
the risk of Emergency Department death in those injured in a region with limited access to trauma 
center care. 
At present, on reaching the scene of the emergency, paramedics must make a voice call to the 
coordination center and transmit information to the on-call physician if they need medical advice 
before taking a decision. Inevitably this “second hand” information is limited and partial, and there is a 
strong risk that potentially valuable information will be lost. In a telemedicine service model, the 
physician at the coordination center has access to signals and measurements from the patient monitor 
and the mechanical ventilator via the video and two-way audio systems of the ambulance cabin. So, 
the decision-making process is based on objective information (as in the hands-on paradigm). 
Furthermore, if the patient needs to be hospitalized, control can be transferred to another physician 
located at the reference hospital who can start managing the case when patient is still on the road. 
Medical emergencies are a growing problem. Statistics from the Department of Health of the United 
Kingdom show that emergency consultations have increased at an annual rate of 6% since 1994. In 
fact, excluding admissions for births, 55% of all hospital admissions go through emergency 
departments. [66] It is well known that delays in diagnosis and treatment are life-threatening situations. 
The benefits of reducing the interval from the injury until the best standard care is instituted are 
obvious, and this window period can clearly be reduced by the use of telemedicine systems.  
4.2. Telemedicine as an Alternative for Treating Chronic Outpatients 
Around 15% of nursing visits can be replaced by home telenursing [67]. This alternative is 
particularly helpful in rural patients [68]. The most relevant aspects of these technical solutions are the Sensors 2010, 10                                       
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simplicity of operation and management, availability, reliability, and affordability [69]. Specifically in 
chronic respiratory patients, one relevant parameter to evaluate is the extent of the airway obstruction 
and its consequences for patients’ oxygenation. Regular testing is often useful in this regard. In 
Bratton’s study [70], 82% of physicians found telecare technology useful as a part of primary-care 
services, but only 45% felt that it could adequately offer a reliable assessment. On the other hand, 61% 
of the patients felt comfortable using the system and 94% did not believe that the technology had 
negative effects on their relationship with their healthcare providers [71]. Other studies have confirmed 
the high degree of satisfaction with this approach among respiratory patients. In an Italian study [72,73], 
a telemonitoring program decreased the number of hospital admissions by around 50%. These results 
were obtained with relatively simple equipment, and measurements were performed only twice a 
week. Although home care programs controlled by telemonitoring are relatively rare at present, 
promising results have been reported in programs with simple internet-based approaches [74], and 
their progressive implementation in the future seems likely. In fact, in Spain, Corral et al. [75,76] have 
proposed a model for specific application in pulmonary care, encompassing not only medical or 
nursing teleconsultation but also forced spirometry, the monitorization of respiratory parameters and 
respiratory rehabilitation. 
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